Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Active Not Recruiting Phase 3 Trials for Daunorubicin (DB00694)

IndicationStatusPhase
DBCOND0028534 (Adult Acute Minimally Differentiated Myeloid Leukemia (M0))Active Not Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02085408Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid LeukemiaTreatment